HIV and hepatitis C.
Gebo
Kelly
K
D000428:Alcohol Drinking; D000998:Antiviral Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology; D022362:Hepatitis A Vaccines / Q000008:administration & dosage; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D016031:Liver Transplantation; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D022362:Hepatitis A Vaccines; D018937:Hepatitis C Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin